カテゴリー： QYResearch, 世界

世界のヘパリン（低分子量）市場 2019年

【英語タイトル】Global Heparin (Low Molecular Weight) Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08951）・商品コード：DATA909X08951
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：103
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ヘパリン（低分子量）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エノキサパリン、ダルテパリン、チンザパリン、フラキシパリンに、用途別には、静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッター電気的除細動、その他にセグメント区分し、ヘパリン（低分子量）の世界市場を分析しました。


・エグゼクティブ・サマリー
・ヘパリン（低分子量）の世界市場概要
・ヘパリン（低分子量）の製造コスト構成分析
・ヘパリン（低分子量）の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ヘパリン（低分子量）の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ヘパリン（低分子量）のセグメント分析（種類別）
（エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）
・ヘパリン（低分子量）のセグメント分析（用途別）
（静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッター電気的除細動、その他）
・ヘパリン（低分子量）の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Aspen、Sanofi-aventis、Pfizer、Opocrin、CSBIO、Dongying Tiandong Pharmaceutical、Changzhou Qianhong Bio-pharma、Techdow、Yantai Dongcheng Pharmaceutical Group、）
・ヘパリン（低分子量）の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Heparin (Low Molecular Weight) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Heparin (Low Molecular Weight) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin (Low Molecular Weight) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Heparin (Low Molecular Weight) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Heparin (Low Molecular Weight) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Aspen
Sanofi-aventis
Pfizer
Opocrin
CSBIO
Dongying Tiandong Pharmaceutical
Changzhou Qianhong Bio-pharma
Techdow
Yantai Dongcheng Pharmaceutical Group

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Enoxaparin
Dalteparin
Tinzaparin
Fraxiparine

Segment by Application
Treatment of Venous Thromboembolism
Complications of Pregnancy
Cardioversion of Atrial Fibrillation/Flutter
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Heparin (Low Molecular Weight)
1.1 Definition of Heparin (Low Molecular Weight)
1.2 Heparin (Low Molecular Weight) Segment by Type
1.2.1 Global Heparin (Low Molecular Weight) Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Enoxaparin
1.2.3 Dalteparin
1.2.4 Tinzaparin
1.2.5 Fraxiparine
1.3 Heparin (Low Molecular Weight) Segment by Applications
1.3.1 Global Heparin (Low Molecular Weight) Consumption Comparison by Applications (2014-2025)
1.3.2 Treatment of Venous Thromboembolism
1.3.3 Complications of Pregnancy
1.3.4 Cardioversion of Atrial Fibrillation/Flutter
1.3.5 Others
1.4 Global Heparin (Low Molecular Weight) Overall Market
1.4.1 Global Heparin (Low Molecular Weight) Revenue (2014-2025)
1.4.2 Global Heparin (Low Molecular Weight) Production (2014-2025)
1.4.3 North America Heparin (Low Molecular Weight) Status and Prospect (2014-2025)
1.4.4 Europe Heparin (Low Molecular Weight) Status and Prospect (2014-2025)
1.4.5 China Heparin (Low Molecular Weight) Status and Prospect (2014-2025)
1.4.6 Japan Heparin (Low Molecular Weight) Status and Prospect (2014-2025)
1.4.7 Southeast Asia Heparin (Low Molecular Weight) Status and Prospect (2014-2025)
1.4.8 India Heparin (Low Molecular Weight) Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Heparin (Low Molecular Weight)
2.3 Manufacturing Process Analysis of Heparin (Low Molecular Weight)
2.4 Industry Chain Structure of Heparin (Low Molecular Weight)

3 Development and Manufacturing Plants Analysis of Heparin (Low Molecular Weight)
3.1 Capacity and Commercial Production Date
3.2 Global Heparin (Low Molecular Weight) Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Heparin (Low Molecular Weight)
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Heparin (Low Molecular Weight) Production and Capacity Analysis
4.2 Heparin (Low Molecular Weight) Revenue Analysis
4.3 Heparin (Low Molecular Weight) Price Analysis
4.4 Market Concentration Degree

5 Heparin (Low Molecular Weight) Regional Market Analysis
5.1 Heparin (Low Molecular Weight) Production by Regions
5.1.1 Global Heparin (Low Molecular Weight) Production by Regions
5.1.2 Global Heparin (Low Molecular Weight) Revenue by Regions
5.2 Heparin (Low Molecular Weight) Consumption by Regions
5.3 North America Heparin (Low Molecular Weight) Market Analysis
5.3.1 North America Heparin (Low Molecular Weight) Production
5.3.2 North America Heparin (Low Molecular Weight) Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Heparin (Low Molecular Weight) Import and Export
5.4 Europe Heparin (Low Molecular Weight) Market Analysis
5.4.1 Europe Heparin (Low Molecular Weight) Production
5.4.2 Europe Heparin (Low Molecular Weight) Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Heparin (Low Molecular Weight) Import and Export
5.5 China Heparin (Low Molecular Weight) Market Analysis
5.5.1 China Heparin (Low Molecular Weight) Production
5.5.2 China Heparin (Low Molecular Weight) Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Heparin (Low Molecular Weight) Import and Export
5.6 Japan Heparin (Low Molecular Weight) Market Analysis
5.6.1 Japan Heparin (Low Molecular Weight) Production
5.6.2 Japan Heparin (Low Molecular Weight) Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Heparin (Low Molecular Weight) Import and Export
5.7 Southeast Asia Heparin (Low Molecular Weight) Market Analysis
5.7.1 Southeast Asia Heparin (Low Molecular Weight) Production
5.7.2 Southeast Asia Heparin (Low Molecular Weight) Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Heparin (Low Molecular Weight) Import and Export
5.8 India Heparin (Low Molecular Weight) Market Analysis
5.8.1 India Heparin (Low Molecular Weight) Production
5.8.2 India Heparin (Low Molecular Weight) Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Heparin (Low Molecular Weight) Import and Export

6 Heparin (Low Molecular Weight) Segment Market Analysis (by Type)
6.1 Global Heparin (Low Molecular Weight) Production by Type
6.2 Global Heparin (Low Molecular Weight) Revenue by Type
6.3 Heparin (Low Molecular Weight) Price by Type

7 Heparin (Low Molecular Weight) Segment Market Analysis (by Application)
7.1 Global Heparin (Low Molecular Weight) Consumption by Application
7.2 Global Heparin (Low Molecular Weight) Consumption Market Share by Application (2014-2019)

8 Heparin (Low Molecular Weight) Major Manufacturers Analysis
8.1 Aspen
8.1.1 Aspen Heparin (Low Molecular Weight) Production Sites and Area Served
8.1.2 Aspen Product Introduction, Application and Specification
8.1.3 Aspen Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Sanofi-aventis
8.2.1 Sanofi-aventis Heparin (Low Molecular Weight) Production Sites and Area Served
8.2.2 Sanofi-aventis Product Introduction, Application and Specification
8.2.3 Sanofi-aventis Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Pfizer
8.3.1 Pfizer Heparin (Low Molecular Weight) Production Sites and Area Served
8.3.2 Pfizer Product Introduction, Application and Specification
8.3.3 Pfizer Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Opocrin
8.4.1 Opocrin Heparin (Low Molecular Weight) Production Sites and Area Served
8.4.2 Opocrin Product Introduction, Application and Specification
8.4.3 Opocrin Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 CSBIO
8.5.1 CSBIO Heparin (Low Molecular Weight) Production Sites and Area Served
8.5.2 CSBIO Product Introduction, Application and Specification
8.5.3 CSBIO Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Dongying Tiandong Pharmaceutical
8.6.1 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Production Sites and Area Served
8.6.2 Dongying Tiandong Pharmaceutical Product Introduction, Application and Specification
8.6.3 Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Changzhou Qianhong Bio-pharma
8.7.1 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Production Sites and Area Served
8.7.2 Changzhou Qianhong Bio-pharma Product Introduction, Application and Specification
8.7.3 Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Techdow
8.8.1 Techdow Heparin (Low Molecular Weight) Production Sites and Area Served
8.8.2 Techdow Product Introduction, Application and Specification
8.8.3 Techdow Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Yantai Dongcheng Pharmaceutical Group
8.9.1 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Production Sites and Area Served
8.9.2 Yantai Dongcheng Pharmaceutical Group Product Introduction, Application and Specification
8.9.3 Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Heparin (Low Molecular Weight) Market
9.1 Global Heparin (Low Molecular Weight) Market Trend Analysis
9.1.1 Global Heparin (Low Molecular Weight) Market Size (Volume and Value) Forecast 2019-2025
9.2 Heparin (Low Molecular Weight) Regional Market Trend
9.2.1 North America Heparin (Low Molecular Weight) Forecast 2019-2025
9.2.2 Europe Heparin (Low Molecular Weight) Forecast 2019-2025
9.2.3 China Heparin (Low Molecular Weight) Forecast 2019-2025
9.2.4 Japan Heparin (Low Molecular Weight) Forecast 2019-2025
9.2.5 Southeast Asia Heparin (Low Molecular Weight) Forecast 2019-2025
9.2.6 India Heparin (Low Molecular Weight) Forecast 2019-2025
9.3 Heparin (Low Molecular Weight) Market Trend (Product Type)
9.4 Heparin (Low Molecular Weight) Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Heparin (Low Molecular Weight) Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Heparin (Low Molecular Weight)
Table Global Heparin (Low Molecular Weight) Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Heparin (Low Molecular Weight) Production Market Share by Types in 2018
Figure Enoxaparin Product Picture
Figure Dalteparin Product Picture
Figure Tinzaparin Product Picture
Figure Fraxiparine Product Picture
Table Global Heparin (Low Molecular Weight) Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Heparin (Low Molecular Weight) Consumption Market Share by Applications in 2018
Figure Treatment of Venous Thromboembolism
Figure Complications of Pregnancy
Figure Cardioversion of Atrial Fibrillation/Flutter
Figure Others
Figure Global Heparin (Low Molecular Weight) Revenue (Million USD) (2014-2025)
Figure Global Heparin (Low Molecular Weight) Production (K Units) (2014-2025)
Figure North America Heparin (Low Molecular Weight) Market Size (Million USD) (2014-2025)
Figure Europe Heparin (Low Molecular Weight) Market Size (Million USD) (2014-2025)
Figure China Heparin (Low Molecular Weight) Market Size (Million USD) (2014-2025)
Figure Japan Heparin (Low Molecular Weight) Market Size (Million USD) (2014-2025)
Figure Southeast Asia Heparin (Low Molecular Weight) Market Size (Million USD) (2014-2025)
Figure India Heparin (Low Molecular Weight) Market Size (Million USD) (2014-2025)
Table Heparin (Low Molecular Weight) Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Heparin (Low Molecular Weight) in 2018
Figure Manufacturing Process Analysis of Heparin (Low Molecular Weight)
Figure Industry Chain Structure of Heparin (Low Molecular Weight)
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Heparin (Low Molecular Weight) Manufacturing Plants Distribution
Table Heparin (Low Molecular Weight) Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Heparin (Low Molecular Weight) Capacity (K Units) of Major Manufacturers (2014-2019)
Table Heparin (Low Molecular Weight) Production (K Units) of Major Manufacturers (2014-2019)
Table Heparin (Low Molecular Weight) Production Market Share of Major Manufacturers (2014-2019)
Figure Heparin (Low Molecular Weight) Production Share by Manufacturers in 2018
Table Heparin (Low Molecular Weight) Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Heparin (Low Molecular Weight) Revenue Market Share of Major Manufacturers (2014-2019)
Figure Heparin (Low Molecular Weight) Revenue Share by Manufacturers in 2018
Table Heparin (Low Molecular Weight) Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Heparin (Low Molecular Weight) Production by Regions 2014-2019 (K Units)
Table Global Heparin (Low Molecular Weight) Production Market Share by Regions 2014-2019
Figure Global Heparin (Low Molecular Weight) Production Market Share by Regions in 2018
Table Global Heparin (Low Molecular Weight) Revenue by Regions 2014-2019 (Million USD)
Table Global Heparin (Low Molecular Weight) Revenue Market Share by Regions 2014-2019
Figure Global Heparin (Low Molecular Weight) Revenue Market Share by Regions in 2018
Table Global Heparin (Low Molecular Weight) Consumption by Regions 2014-2019 (K Units)
Table Global Heparin (Low Molecular Weight) Consumption Market Share by Regions 2014-2019
Figure North America Heparin (Low Molecular Weight) Production Growth Rate 2014-2019 (K Units)
Figure North America Heparin (Low Molecular Weight) Revenue Growth Rate 2014-2019 (Million USD)
Table North America Heparin (Low Molecular Weight) Production, Consumption Import and Export (K Units)
Figure Europe Heparin (Low Molecular Weight) Production Growth Rate 2014-2019 (K Units)
Figure Europe Heparin (Low Molecular Weight) Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Heparin (Low Molecular Weight) Production, Consumption Import and Export (K Units)
Figure China Heparin (Low Molecular Weight) Production Growth Rate 2014-2019 (K Units)
Figure China Heparin (Low Molecular Weight) Revenue Growth Rate 2014-2019 (Million USD)
Table China Heparin (Low Molecular Weight) Production, Consumption Import and Export (K Units)
Figure Japan Heparin (Low Molecular Weight) Production Growth Rate 2014-2019 (K Units)
Figure Japan Heparin (Low Molecular Weight) Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Heparin (Low Molecular Weight) Production, Consumption Import and Export (K Units)
Figure Southeast Asia Heparin (Low Molecular Weight) Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Heparin (Low Molecular Weight) Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Heparin (Low Molecular Weight) Production, Consumption Import and Export (K Units)
Figure India Heparin (Low Molecular Weight) Production Growth Rate 2014-2019 (K Units)
Figure India Heparin (Low Molecular Weight) Revenue Growth Rate 2014-2019 (Million USD)
Table India Heparin (Low Molecular Weight) Production, Consumption Import and Export (K Units)
Figure Global Consumption Heparin (Low Molecular Weight) Market Share by Application (2014-2019)
Figure Global Value (Consumption) Heparin (Low Molecular Weight) Market Share by Application (2014-2019)
Table Aspen Heparin (Low Molecular Weight) Production Sites and Area Served
Table Aspen Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Aspen Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aspen Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Aspen Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Aspen Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Aspen Heparin (Low Molecular Weight) Main Business and Markets Served
Table Sanofi-aventis Heparin (Low Molecular Weight) Production Sites and Area Served
Table Sanofi-aventis Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Sanofi-aventis Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi-aventis Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Sanofi-aventis Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Sanofi-aventis Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Sanofi-aventis Heparin (Low Molecular Weight) Main Business and Markets Served
Table Pfizer Heparin (Low Molecular Weight) Production Sites and Area Served
Table Pfizer Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Pfizer Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Pfizer Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Pfizer Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Pfizer Heparin (Low Molecular Weight) Main Business and Markets Served
Table Opocrin Heparin (Low Molecular Weight) Production Sites and Area Served
Table Opocrin Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Opocrin Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Opocrin Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Opocrin Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Opocrin Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Opocrin Heparin (Low Molecular Weight) Main Business and Markets Served
Table CSBIO Heparin (Low Molecular Weight) Production Sites and Area Served
Table CSBIO Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table CSBIO Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table CSBIO Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table CSBIO Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure CSBIO Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table CSBIO Heparin (Low Molecular Weight) Main Business and Markets Served
Table Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Production Sites and Area Served
Table Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Dongying Tiandong Pharmaceutical Heparin (Low Molecular Weight) Main Business and Markets Served
Table Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Production Sites and Area Served
Table Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Changzhou Qianhong Bio-pharma Heparin (Low Molecular Weight) Main Business and Markets Served
Table Techdow Heparin (Low Molecular Weight) Production Sites and Area Served
Table Techdow Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Techdow Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Techdow Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Techdow Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Techdow Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Techdow Heparin (Low Molecular Weight) Main Business and Markets Served
Table Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Production Sites and Area Served
Table Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Product Introduction, Application and Specification
Table Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Production Growth Rate (2014-2019)
Table Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Production Market Share (2014-2019)
Figure Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Revenue Market Share (2014-2019)
Table Yantai Dongcheng Pharmaceutical Group Heparin (Low Molecular Weight) Main Business and Markets Served
Figure Global Heparin (Low Molecular Weight) Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Heparin (Low Molecular Weight) Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Heparin (Low Molecular Weight) Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Heparin (Low Molecular Weight) Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Heparin (Low Molecular Weight) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Heparin (Low Molecular Weight) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Heparin (Low Molecular Weight) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Heparin (Low Molecular Weight) Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Heparin (Low Molecular Weight) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Heparin (Low Molecular Weight) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Heparin (Low Molecular Weight) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Heparin (Low Molecular Weight) Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Heparin (Low Molecular Weight) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Heparin (Low Molecular Weight) Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Heparin (Low Molecular Weight) Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Heparin (Low Molecular Weight) by Type (2019-2025)
Table Global Consumption (K Units) of Heparin (Low Molecular Weight) by Application (2019-2025)
Table Heparin (Low Molecular Weight) Distributors List
Table Heparin (Low Molecular Weight) Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Aspen、Sanofi-aventis、Pfizer、Opocrin、CSBIO、Dongying Tiandong Pharmaceutical、Changzhou Qianhong Bio-pharma、Techdow、Yantai Dongcheng Pharmaceutical Group、

★調査レポート[世界のヘパリン（低分子量）市場 2019年] (コード：DATA909X08951)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヘパリン（低分子量）市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）市場 2019年
    DATA909X08953 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヘパリンナトリウム、ヘパリンカルシウムに、用途別には、未分画ヘパリン、低分子ヘパリンAPIにセグメント区分し、ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の世界市場概要 ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の製造コスト構成分析 ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヘパリン（ヘパリンナトリウム及びヘパリンカルシウム）のセグメント分析（種類別） （ヘパリンナトリウム、ヘパリンカルシウム）...The global Heparin(Heparin Sodium and Heparin Calcium) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin(Heparin Sodium and Heparin Calcium) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin(Heparin Sodium and Heparin Calcium) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Heparin(Heparin Sodium and Heparin Calcium) in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の低分子量ヘパリンナトリウム市場 2019年
    DATA909X10732 / QYResearch / 2019年11月20日 / ※本調査レポートは、低分子量ヘパリンナトリウムの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エノキサパリン、ダルテパリン、チンザパリン、フラキシパリンに、用途別には、医療、研究にセグメント区分し、低分子量ヘパリンナトリウムの世界市場を分析しました。 ・エグゼクティブ・サマリー ・低分子量ヘパリンナトリウムの世界市場概要 ・低分子量ヘパリンナトリウムの製造コスト構成分析 ・低分子量ヘパリンナトリウムの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・低分子量ヘパリンナトリウムの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・低分子量ヘパリンナトリウムのセグメント分析（種類別） （エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）...The global Low Molecular Weight Heparin Sodium market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Low Molecular Weight Heparin Sodium volume and value at global level, regional level and company level. From a global perspective, this report represents overall Low Molecular Weight Heparin Sodium market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Low Molecular Weight Heparin Sodium in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の低分子量ヘパリン（LMWH）市場 2019年
    DATA909X10731 / QYResearch / 2019年11月20日 / ※本調査レポートは、低分子量ヘパリン（LMWH）の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エノキサパリン、ダルテパリン、チンザパリン、フラキシパリンに、用途別には、静脈血栓塞栓症治療、妊娠合併症、心房細動/フラッター電気的除細動、その他にセグメント区分し、低分子量ヘパリン（LMWH）の世界市場を分析しました。 ・エグゼクティブ・サマリー ・低分子量ヘパリン（LMWH）の世界市場概要 ・低分子量ヘパリン（LMWH）の製造コスト構成分析 ・低分子量ヘパリン（LMWH）の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・低分子量ヘパリン（LMWH）の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・低分子量ヘパリン（LMWH）のセグメント分析（種類別） （エノキサパリン、ダルテパリン、チンザパリン、フラキシパリン）...The global Low Molecular Weight Heparin (LMWHs) market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Low Molecular Weight Heparin (LMWHs) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Low Molecular Weight Heparin (LMWHs) market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Low Molecular Weight Heparin (LMWHs) in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のDNA分子量マーカー市場 2019年
    DATA909X06692 / QYResearch / 2019年11月15日 / ※本調査レポートは、DNA分子量マーカーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、50塩基対（bp）未満、50 bpから100 bp、100 bpから1キロ塩基対（kb）、1 kbから5 kb、5 kb以上に、用途別には、PCR、シーケンシング、ノーザンブロッティング、サザンブロッティング、分子クローニング、その他にセグメント区分し、DNA分子量マーカーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・DNA分子量マーカーの世界市場概要 ・DNA分子量マーカーの製造コスト構成分析...The global DNA Molecular Weight Marker market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on DNA Molecular Weight Marker volume and value at global level, regional level and company level. From a global perspective, this report represents overall DNA Molecular Weight Marker market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of DNA Molecular Weight Marker in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の分子量アナライザー市場 2019年
    DATA909X11617 / QYResearch / 2019年11月20日 / ※本調査レポートは、分子量アナライザーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ゲル浸透クロマトグラフィー（GPC）、ガスクロマトグラフィー＆質量分析（GC / MS）、サイズ排除クロマトグラフィー（SEC）、高速液体クロマトグラフィー（HPLC）、示差屈折率（DRI）、マルチアングルレーザー光散乱（MALLS）に、用途別には、医学、薬学研究、実験室、その他にセグメント区分し、分子量アナライザーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・分子量アナライザーの世界市場概要 ・分子量アナライザーの製造コスト構成分析 ・分子量アナライザーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・分子量アナライザーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド）...The global Molecular Weight Analyzer market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Molecular Weight Analyzer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Molecular Weight Analyzer market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Molecular Weight Analyzer in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のヘパリン有効成分市場 2019年
    DATA909X08952 / QYResearch / 2019年11月20日 / ※本調査レポートは、ヘパリン有効成分の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ヘパリンナトリウム、ヘパリンカルシウム、その他に、用途別には、UFH、LMWHにセグメント区分し、ヘパリン有効成分の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ヘパリン有効成分の世界市場概要 ・ヘパリン有効成分の製造コスト構成分析 ・ヘパリン有効成分の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ヘパリン有効成分の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ヘパリン有効成分のセグメント分析（種類別） （ヘパリンナトリウム、ヘパリンカルシウム、その他）...The global Heparin Active Pharmaceutical Ingredients market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Heparin Active Pharmaceutical Ingredients volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin Active Pharmaceutical Ingredients market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Heparin Active Pharmaceutical Ingredients in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のペプチド及びヘパリン市場 2019年
    DATA909X12781 / QYResearch / 2019年11月20日 / ※本調査レポートは、ペプチド及びヘパリンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウムに、用途別には、糖尿病、感染症、がん、骨粗鬆症にセグメント区分し、ペプチド及びヘパリンの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ペプチド及びヘパリンの世界市場概要 ・ペプチド及びヘパリンの製造コスト構成分析 ・ペプチド及びヘパリンの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ペプチド及びヘパリンの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ペプチド及びヘパリンのセグメント分析（種類別） （インスリン、テリパラチド、リラグルチド、ロイプロリド、ロイプロリド、エクセナチド、カルシトニン、エナキサパリンナトリウム、ヘパリンナトリウム）...The global Peptides and Heparin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Peptides and Heparin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peptides and Heparin market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Peptides and Heparin in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆